Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
Despite widespread use of respiratory protective equipment in the U.S. healthcare workplace, there is very little clinical evidence that respirators prevent healthcare personnel (HCP) from airborne infectious diseases. Scientific investigation of this issue has been quite complicated, primarily because the use of respirators has become "the standard of care" for protection against airborne diseases in some instances, even without sufficient evidence to support their use. The key question remains: How well do respirators prevent airborne infectious diseases? The answer to this important question has important medical, public health, political and economic implications.
Description: Number of influenza A and B events in healthcare practitioners wearing N95 respirators compared to medical masks.
Measure: Protective Effects of N95 Respirators vs Medical Masks (MM) as Assessed by Number of Influenza A and B Events Time: 60 weeksDescription: Number of influenza-like illnesses in healthcare practitioners wearing N95 respirators compared to medical masks.
Measure: Protective Effects of N95 Respirators vs Medical Masks as Assessed by Number of Influenza-like Illnesses Time: 60 weeksDescription: Number of lab confirmed respiratory illnesses in healthcare practitioners wearing N95 respirators compared to medical masks.
Measure: Protective Effects of N95 Respirators vs Medical Masks as Assessed by Number of Lab Confirmed Respiratory Illnesses Time: 60 weeksDescription: Number of lab detected respiratory infections in healthcare practitioners wearing N95 respirators compared to medical masks.
Measure: Protective Effects of N95 Respirators vs Medical Masks as Assessed by Number of Lab Detected Respiratory Infections Time: 60 weeksDescription: Number of acute respiratory illnesses in healthcare practitioners wearing N95 respirators compared to medical masks.
Measure: Protective Effects of N95 Respirators vs Medical Masks as Assessed by Number of Acute Respiratory Illnesses Time: 60 weeksDescription: Number of laboratory confirmed influenza illnesses in healthcare practitioners wearing N95 respirators compared to medical masks.
Measure: Protective Effects of N95 Respirators vs Medical Masks as Assessed by Number of Laboratory Confirmed Illness Time: 60 weeksAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports